Answers are grounded in this paper and cite their sources.
This multi-centre survey identified a concerning median inter-centre variation of 21 % in cumulative reRT dose constraints, indicating substantial heterogeneity in current clinical practices. Further prospective studies with rigorous and standardized dose reporting are essential to refine reRT guidelines, enhancing patient safety and treatment efficacy.
No takes yet. Share an insight, caveat, or question.
Stroom et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: